A not for profit organisation

Request an appointment
Banner Image

The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis.

Home Research Research Publication The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis.

Yu T, Forrester JV, Graham GJ, Kuffova L. The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis. Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1875-1882. doi: 10.1007/s00417-018-4070-1. Epub 2018 Jul 27. PMID: 30054731

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Phone
(08) 9381 0777
Email
carecentre@lei.org.au

Request an appointment